Maravai LifeSciences Holdings Inc (MRVI) Noticias

Maravai LifeSciences Reports Third Quarter 2024 Financial Results

Announces Agreement to Acquire the DNA and RNA business of Officinae Bio, Advancing Support for Innovative...

Form 4 - Statement of changes in beneficial ownership of securities

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global...

TriLink BioTechnologies® und Alphazyme bringen die neue CleanScribe™ RNA Polymerase auf den Markt

Arzneimittelentwicklern und Forschern können ab sofort das CleanScribe-Enzym nutzen, um die Bildung von dsRNA bei der mRNA-Synthese um bis zu 85...

TriLink BioTechnologies® et Alphazyme collaborent pour lancer la nouvelle ARN polymérase CleanScribe™

Les développeurs de médicaments et les chercheurs peuvent désormais tirer parti de l’enzyme CleanScribe pour réduire la formation d’ARNdb jusqu’à...

TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase

Drug developers & researchers can now leverage the CleanScribe enzyme to reduce dsRNA formation by up to 85% in mRNA synthesis without...

Form 8-K - Current report

Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits

Cygnus’ AccuRes Kits to recover, amplify, & quantify remaining host cell DNA during biologic drug manufacturing to produce safer, more stable...

Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule

SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Maravai LifeSciences Reports Second Quarter 2024 Financial Results

SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a...

Form 8-K - Current report

Maravai LifeSciences Appoints Trey Martin to Board of Directors

SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of...